Metabolic dysfunction-associated steatotic liver disease (MASLD) significantly increases the risk of developing hepatocellular carcinoma (HCC) in patients with type 2 diabetes, according to results of ...

Disability insurance applications and appeals (18.6%).

Recent reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and research funding in jeopardy.

Research links environmental exposures to CKD development and progression. Here’s what clinicians and patients need to know.